Executive Summary
Purpose of the Conference
Chairman's Summary
Use of Nonviral Vectors for Cystic Fibrosis Gene Therapy
Physical and Biological Barriers to Viral Vector-mediated Delivery of Genes to the Airway Epithelium
Adeno-associated Virus and Lentivirus Pseudotypes for Lung-directed Gene Therapy
Deposition of Inhaled Particles in the Human Respiratory Tract and Consequences for Regional Targeting in Respiratory Drug Delivery
Drug Delivery Devices
Imaging Drug Delivery and Drug Responses in the Lung
The Lungs as a Portal of Entry for Systemic Drug Delivery
Distribution of Receptor Targets in the Lung
Designing Corticosteroid Drugs for Pulmonary Selectivity
How the Lung Handles Drugs
Asthma Steroid Pharmacogenetics